These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28627218)

  • 1. Performance evaluation of three platforms with ultrasensitive ligand-binding assay potential.
    Cowan KJ; Geiger A; Hornauer H; Rourick R; Siguenza PY
    Bioanalysis; 2017 Jun; 9(12):937-946. PubMed ID: 28627218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of highly sensitive immunoassay technologies for quantitative measurements of sub-pg/mL levels of cytokines in human serum.
    Yeung D; Ciotti S; Purushothama S; Gharakhani E; Kuesters G; Schlain B; Shen C; Donaldson D; Mikulskis A
    J Immunol Methods; 2016 Oct; 437():53-63. PubMed ID: 27555238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-platform comparison of highly sensitive immunoassay technologies for cytokine markers: Platform performance in post-traumatic stress disorder and Parkinson's disease.
    Lasseter HC; Provost AC; Chaby LE; Daskalakis NP; Haas M; Jeromin A
    Cytokine X; 2020 Jun; 2(2):100027. PubMed ID: 33604555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioanalytical challenges in development of ultrasensitive Home Brew assays: a case study using IL-13.
    Sperinde G; Hokom M; Peng K; Fischer SK
    Bioanalysis; 2019 Jun; 11(11):1045-1054. PubMed ID: 31251105
    [No Abstract]   [Full Text] [Related]  

  • 5. Measurement of IL-21 in human serum and plasma using ultrasensitive MSD S-PLEX® and Quanterix SiMoA methodologies.
    Poorbaugh J; Samanta T; Bright SW; Sissons SE; Chang CY; Oberoi P; MacDonald AJ; Martin AP; Cox KL; Benschop RJ
    J Immunol Methods; 2019 Mar; 466():9-16. PubMed ID: 30590020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of biofluid cytokine markers across platform technologies: Correspondence or divergence?
    Casaletto KB; Elahi FM; Fitch R; Walters S; Fox E; Staffaroni AM; Bettcher BM; Zetterberg H; Karydas A; Rojas JC; Boxer AL; Kramer JH
    Cytokine; 2018 Nov; 111():481-489. PubMed ID: 29908923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Multi-site In-depth Evaluation of the Quanterix Simoa from a User's Perspective.
    Chunyk AG; Joyce A; Fischer SK; Dysinger M; Mikulskis A; Jeromin A; Lawrence-Henderson R; Baker D; Yeung D
    AAPS J; 2017 Dec; 20(1):10. PubMed ID: 29196830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Bead-Based Fluorescence Versus Planar Electrochemiluminescence Multiplex Immunoassays for Measuring Cytokines in Human Plasma.
    Günther A; Becker M; Göpfert J; Joos T; Schneiderhan-Marra N
    Front Immunol; 2020; 11():572634. PubMed ID: 33101295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging technologies to increase ligand binding assay sensitivity.
    Fischer SK; Joyce A; Spengler M; Yang TY; Zhuang Y; Fjording MS; Mikulskis A
    AAPS J; 2015 Jan; 17(1):93-101. PubMed ID: 25331105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine Profiling in Plasma from Patients with Brain Tumors Versus Healthy Individuals using 2 Different Multiplex Immunoassay Platforms.
    Bender DE; Schaettler MO; Sheehan KC; Johanns TM; Dunn GP
    Biomark Insights; 2021; 16():11772719211006666. PubMed ID: 33854293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative determination of human interleukin 22 (IL-22) in serum using Singulex-Erenna® technology.
    Shukla R; Santoro J; Bender FC; Laterza OF
    J Immunol Methods; 2013 Apr; 390(1-2):30-4. PubMed ID: 23313291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analytical validation of a highly sensitive microparticle-based immunoassay for the quantitation of IL-13 in human serum using the Erenna immunoassay system.
    St Ledger K; Agee SJ; Kasaian MT; Forlow SB; Durn BL; Minyard J; Lu QA; Todd J; Vesterqvist O; Burczynski ME
    J Immunol Methods; 2009 Oct; 350(1-2):161-70. PubMed ID: 19732777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization and qualification of the single molecule array digital immunoassay for IL-12p70 in plasma of cancer patients.
    Gupta V; Kalia N; Yadav M; Noyes A; Good J; Hendricks R; Xu W
    Bioanalysis; 2018 Sep; 10(17):1413-1425. PubMed ID: 30182727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commercial biomarker assays: friend and foe.
    Fischer SK; Carrasco-Triguero M; Hong K; Good J; Davancaze T; Nguy T; Li J; Darbonne W; Morimoto A; Zhu Y
    Bioanalysis; 2016 Nov; 8(22):2351-2362. PubMed ID: 27704870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical performance of a commercial multiplex Luminex-based cytokine panel in the rat.
    Erkens T; Goeminne N; Kegels A; Byloos M; Vinken P
    J Pharmacol Toxicol Methods; 2018; 91():43-49. PubMed ID: 29371052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative multicentre study of a panel of thyroid tests using different automated immunoassay platforms and specimens at high risk of antibody interference.
    Martel J; Després N; Ahnadi CE; Lachance JF; Monticello JE; Fink G; Ardemagni A; Banfi G; Tovey J; Dykes P; John R; Jeffery J; Grant AM
    Clin Chem Lab Med; 2000 Aug; 38(8):785-93. PubMed ID: 11071074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analytical comparison of three immunoassay platforms for subpicomolar detection of protein biomarker GAD65.
    Costa OR; Verhaeghen K; Roels S; Stangé G; Ling Z; Pipeleers D; Gorus FK; Martens GA
    PLoS One; 2018; 13(3):e0193670. PubMed ID: 29518118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa.
    Kuhle J; Barro C; Andreasson U; Derfuss T; Lindberg R; Sandelius Å; Liman V; Norgren N; Blennow K; Zetterberg H
    Clin Chem Lab Med; 2016 Oct; 54(10):1655-61. PubMed ID: 27071153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the MesoScale Discovery and Luminex multiplex platforms for measurement of urinary biomarkers in a cisplatin rat kidney injury model.
    Pavkovic M; Riefke B; Gutberlet K; Raschke M; Ellinger-Ziegelbauer H
    J Pharmacol Toxicol Methods; 2014; 69(2):196-204. PubMed ID: 24333954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of four distinct detection platforms using multiple ligand binding assay formats.
    Soderstrom CI; Spriggs FP; Song W; Burrell S
    J Immunol Methods; 2011 Aug; 371(1-2):106-13. PubMed ID: 21749873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.